Clinical Trial

Low-dose Buprenorphine Initiation for Opioid Use Disorder

Name: Low-dose Buprenorphine Initiation for Opioid Use Disorder — clinical trial record (NCT05450718)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 4

View on ClinicalTrials.gov →

Summary

The purpose of this study is to test whether low-dose buprenorphine initiation for treatment of opioid use disorder is safe and effective.

Protocol Amendment History 21 amendments

This ClinicalTrials.gov record has been amended 21 times since 2022-07-06; most recent amendment 2026-07-17.

Status change: Not Yet Recruiting → Recruiting 2024-02-05

Trial Details

NCT Number	NCT05450718
Lead Sponsor	Montefiore Medical Center Collaborators: National Institute on Drug Abuse (NIDA)
Conditions	Opioid Use Disorder
Enrollment	70 participants
Start Date	2024-11-11
Primary Completion	2027-03-17 (estimated)
Study Completion	2027-06-30 (estimated)
Updated on ClinicalTrials.gov	2026-07-21